BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TetraPhase Pharmaceuticals 

480 Arsenal Street
Suite 110
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-715-3600 Fax: 617-926-3557


SEARCH JOBS




Industry
Biotechnology






 Company News
TetraPhase Pharmaceuticals Completes Enrollment in Lead-in Portion of IGNITE 2 Eravacycline Phase 3 Clinical Trial in cUTI 6/19/2014 10:20:47 AM
TetraPhase Pharmaceuticals Adds Dr. Jeffrey Chodakewitz To Board Of Directors 6/17/2014 1:24:13 PM
TetraPhase Pharmaceuticals To Present At Upcoming Conferences 6/16/2014 9:07:34 AM
TetraPhase Pharmaceuticals To Present At The Annual UBS Global Healthcare Conference 5/14/2014 7:25:36 AM
TetraPhase Pharmaceuticals To Present Data On Advancing Product Pipeline At 24th ECCMID 5/12/2014 6:59:19 AM
FDA Awards Fast Track Status To TetraPhase Pharmaceuticals For IV And Oral Formulations Of Eravacycline 4/2/2014 10:10:54 AM
TetraPhase Pharmaceuticals To Present At Upcoming Investor Conferences 3/21/2014 7:15:27 AM
TetraPhase Pharmaceuticals Provides Update On Clinical Progress Of Phase 3 Lead Antibiotic Candidate Eravacycline 3/20/2014 10:13:33 AM
TetraPhase Pharmaceuticals Adds Nancy J. Wysenski To Board Of Directors 3/13/2014 6:59:03 AM
TetraPhase Pharmaceuticals Reports Fourth-Quarter And Full-Year 2013 Financial Results 3/6/2014 7:23:39 AM
1234567